Medical Developments International Limited (ASX:MVP)

Market Cap	49.01M -48.2%
Revenue (ttm)	40.64M +6.8%
Net Income	-436.00K
EPS	-0.00
Shares Out	112.66M
PE Ratio	n/a
Forward PE	326.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103,713
Average Volume	105,501
Open	0.4350
Previous Close	0.4300
Day's Range	0.4200 - 0.4350
52-Week Range	0.4200 - 0.7650
Beta	1.44
RSI	40.04
Earnings Date	Feb 19, 2026

About ASX:MVP

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow mete...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP